首页> 外文期刊>Trends in pharmacological sciences >Acquired somatic mutations in the molecular pathogenesis of COPD.
【24h】

Acquired somatic mutations in the molecular pathogenesis of COPD.

机译:COPD分子发病机制中的获得性体细胞突变。

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic obstructive pulmonary disease (COPD) is caused mostly by cigarette smoking but its specific molecular mechanisms are obscure. Current theories suggest that the inflammation and oxidative stress induced by smoking lead to proteolytic imbalance and progressive lung structural derangement, with disease susceptibility being controlled by inherited variations in protective or inflammatory genes. However, cigarette smoke is directly mutagenic. Acquired somatic mutations, rather than inherited polymorphisms, might therefore be major determinants of COPD. Somatic mutations in oncogenes such as p53, Ras, EGFR and PTEN abound in the epithelium of smokers. These mutations are persistent, explaining the paradox that smoking cessation does not resolve inflammation. Moreover, the recognition that these somatic mutations converge on key inflammation, host defense and steroid response pathways might help to explain the clinical defects in these processes in COPD and guide discovery of future therapies.
机译:慢性阻塞性肺疾病(COPD)主要由吸烟引起,但其具体的分子机制尚不清楚。当前的理论表明,吸烟引起的炎症和氧化应激会导致蛋白水解失衡和进行性肺结构紊乱,疾病易感性由保护性或炎症性基因的遗传变异控制。但是,香烟烟雾是直接诱变的。因此,获得性体细胞突变而不是遗传多态性可能是COPD的主要决定因素。吸烟者上皮中存在p53,Ras,EGFR和PTEN等癌基因的体细胞突变。这些突变是持续的,这解释了自相矛盾的事实,即戒烟不能解决炎症。此外,认识到这些体细胞突变在关键炎症,宿主防御和类固醇应答途径上会聚,可能有助于解释COPD在这些过程中的临床缺陷,并指导未来疗法的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号